Drug intelligence / Profile preview

naphazoline + methylthioninium hydroxide

Development stage
Unknown
Lead developer
FRiLAB
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Collyre Bleu (also known as Collyre Bleu Laiter) is an approved ophthalmic combination drug containing naphazoline nitrate, a vasoconstrictor, and methylthioninium hydroxide (methylene blue), a mild antiseptic and optical brightener. Developed by FRiLAB, it is indicated for the temporary relief of eye redness, irritation, and noninfectious conjunctivitis. Naphazoline acts as an agonist on alpha-adrenergic receptors, causing vasoconstriction of the conjunctival blood vessels to reduce redness and congestion. Methylthioninium hydroxide provides a mild antiseptic effect and imparts a blue tint that acts as an optical brightener, visually counteracting yellow or dull tones in the sclera to make the eyes appear whiter and brighter.

Brand names
CentiluxCollyre BleuCollyre Bleu Laiter
Other names
naphazoline + methylene bluenaphazoline nitrate + methylene bluenaphazoline nitrate + methylthioninium hydroxide
02

Targets

ADRA1B (α1B)ADRA1D (α1D)ADRA2A (α2A)ADRA2B (α2B)ADRA2C (α2C)ADRA1A (α1A)

Beyond the preview

Go deeper on naphazoline + methylthioninium hydroxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on naphazoline + methylthioninium hydroxide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call